Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report.

Hsieh-Wong, Jacqueline; Liu, James; Huynh, Jasmine; Parikh, Mamta; Kim, Edward; Gong, Jun; Halabi, Wissam; Siricilla, Mamatha; Mitra, Anupam; Toomey, Kyra; Cho, May

Hsieh-Wong, Jacqueline; Liu, James; Huynh, Jasmine; Parikh, Mamta; Kim, Edward; Gong, Jun; Halabi, Wissam; Siricilla, Mamatha; Mitra, Anupam; Toomey, Kyra; Cho, May.

Afiliación

Hsieh-Wong J; UC Davis Medical Center, Sacramento, CA, USA.
Liu J; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Huynh J; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Parikh M; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Kim E; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Gong J; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles, CA, USA.
Halabi W; Department of Colorectal Surgery, UC Davis Medical Center, Sacramento, CA, USA.
Siricilla M; Division of Hematology and Oncology, Marshall Medical Center, Cameron Park, CA, USA.
Mitra A; Department of Pathology, UC Davis Medical Center, Sacramento, CA, USA.
Toomey K; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Cho M; UC Irvine Comprehensive Cancer Center, Orange, CA, USA.

J Gastrointest Oncol ; 13(3): 1473-1480, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35837187

Palabras clave

Rectal adenocarcinoma; case report; immunotherapy; microsatellite instability-high (MSI-H); upper tract urothelial carcinoma (UTUC)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Gastrointest Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos